| Literature DB >> 22935537 |
Joana C Guedes1, Jeong-Hui Park, Nilay J Lakhkar, Hae-Won Kim, Jonathan C Knowles, Ivan B Wall.
Abstract
Scalable expansion of cells for regenerative cell therapy or to produce large quantities for high-throughput screening remains a challenge for bioprocess engineers. Laboratory scale cell expansion using t-flasks requires frequent passaging that exposes cells to many poorly defined bioprocess forces that can cause damage or alter their phenotype. Microcarriers offer a potential solution to scalable production, lending themselves to cell culture processes more akin to fermentation, removing the need for frequent passaging throughout the expansion period. One main problem with microcarrier expansion, however, is the difficulty in harvesting cells at the end of the process. Therefore, therapies that rely on cell delivery using biomaterial scaffolds could benefit from a microcarrier expansion system whereby the cells and microcarriers are transplanted together. In the current study, we used bioactive glass microcarriers doped with 5% TiO₂ that display a controlled rate of degradation and conducted experiments to assess biocompatibility and growth of primary fibroblast cells as a model for cell therapy products. We found that the microcarriers are highly biocompatible and facilitate cell growth in a gradual controlled manner. Therefore, even without additional biofunctionalization methods, Ti-doped bioactive glass microcarriers offer potential as a cell expansion platform.Entities:
Keywords: Microcarriers; bioactive phosphate-based glass; cell expansion; titanium
Mesh:
Substances:
Year: 2012 PMID: 22935537 PMCID: PMC4107757 DOI: 10.1177/0885328212459093
Source DB: PubMed Journal: J Biomater Appl ISSN: 0885-3282 Impact factor: 2.646
Glass structural composition.
| Glass compositions (mol%) | ||||
|---|---|---|---|---|
| Glass codes | P2O5 | CaO | Na2O | TiO2 |
| P50C40N7Ti3 (Ti3) | 50 | 40 | 7 | 3 |
| P50C40N5Ti5 (Ti5) | 50 | 40 | 5 | 5 |
| P50C40N3Ti7 (Ti7) | 50 | 40 | 3 | 7 |
Figure 1.(A) Microcarrier degradation and (B) associated Ca2+ release from Ti3, Ti5 and Ti7 microcarriers over time in deionized water. (C) Light micrograph of microscopic appearance and (D) size distribution histogram of Ti5 microcarriers used in subsequent experiments. Bar = 100 µm.
Release rate of ionic constituents from microcarriers.
| Glass code | Ti3 | Ti5 | Ti7 |
|---|---|---|---|
| Anion (ppm h−1) | |||
| | 37.921 | 5.2563 | 3.6023 |
| | 46.864 | 13.304 | 7.4739 |
| | 15.084 | 3.2237 | 2.2045 |
| | 18.761 | 8.1531 | 5.5788 |
| Cation (ppm h−1) | |||
| Ca2+ | 45.778 | 15.202 | 7.462 |
| Na+ | 15.571 | 1.9666 | 0.772 |
Figure 2.(A) Phase-contrast and (B) DAPI staining of fibroblasts seeded onto standard tissue culture plastic dispersed with microcarriers after 24 h. (C–D) Adhesion of fibroblasts to microcarriers in ultra-low attachment microwell plates 72 h after seeding. (E) Clear cell adhesion and growth on microcarriers is evident with propidium iodide (PI) staining at high power after 72 h. Bar = 100 µm.
Figure 3.Morphology of fibroblasts cultured on 5 mol% TiO2-doped microcarriers. Green = phalloidin f-actin; Red = propidium iodide; arrows = focal adhesions; arrowhead = dividing cell. Bar = 100 µm.
Figure 4.Proliferation of fibroblasts cultured on 5 mol% TiO2-doped microcarriers and on standard tissue culture plastic. Values = mean ± standard deviation.
Figure 5.(A) Phase contrast and (B) fluorescent images of fibroblasts labelled with Vibrant DiO after 24 h. (C–K) Scanning electron microscopy (SEM) images showing morphology of fibroblasts over time. Bar A, B, E, H, K = 100 µm; C, D, F, G, I, J = 70 µm.